Development and validation of the method of quantification of 5-[5-(trifluoromethyl)-1,2-oxazole-3-yl]-furan-2-sulfonamide and its metabolites in laboratory animal plasma by I. I. Yaichkov, M. K. Korsakov, A. A. Shetnev, N. N. Volkhin, S. S. Petukhov

Get full text

The excretion study of a new derivative of 4,5-dihydroisoxazole-5-carboxamide by I. I. Yaichkov, M. K. Korsakov, N. N. Volkhin, V. E. Zaykova, O. E. Lasaraynz

Get full text

Pharmacokinetics Study of a New Isoxazole Derivative in Rats Using HPLC-MS/MS for Blood Sample Analysis by I. I. Yaichkov, A. L. Khokhlov, M. K. Korsakov, A. A. Shetnev, N. N. Volkhin, S. S. Petukhov

Get full text

Pharmacokinetic study of a new 4,5-dihydroisoxazole-5-carboxamide derivative in rats by I. I. Yaichkov, M. K. Korsakov, N. N. Volkhin, S. S. Petukhov, A. N. Tyushina, V. E. Zaykova, O. E. Lasaraynz

Get full text

Study of biotransformation of new selective carbonic anhydrase II inhibitor 4-(2-methyl-1,3-oxazole-5-yl)-benzenesulfonamide by A. L. Khokhlov, I. I. Yaichkov, A. A. Shetnev, S. A. Ivanovskiy, M. K. Korsakov, O. A. Gasilina, N. N. Volkhin, S. S. Petukhov

Get full text